Pricing of Drugs Codeveloped by Federal Laboratories and Private Companies: Hearing Before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, First Session, Washington, DC, January 25, 1993, Volume 4

· U.S. Government Printing Office
Электрон ном
237
Хуудас

Энэ электрон номын тухай

Энэ электрон номыг үнэлэх

Санал бодлоо хэлнэ үү.

Унших мэдээлэл

Ухаалаг утас болон таблет
Андройд болон iPad/iPhone-д Google Ном Унших аппыг суулгана уу. Үүнийг таны бүртгэлд автоматаар синк хийх бөгөөд та хүссэн газраасаа онлайн эсвэл офлайнаар унших боломжтой.
Зөөврийн болон ердийн компьютер
Та компьютерийн веб хөтчөөр Google Play-с авсан аудио номыг сонсох боломжтой.
eReaders болон бусад төхөөрөмжүүд
Kobo Цахим ном уншигч гэх мэт e-ink төхөөрөмжүүд дээр уншихын тулд та файлыг татаад төхөөрөмж рүүгээ дамжуулах шаардлагатай болно. Файлуудаа дэмжигддэг Цахим ном уншигч руу шилжүүлэхийн тулд Тусламжийн төвийн дэлгэрэнгүй зааварчилгааг дагана уу.

United States. Congress. House. Committee on Small Business. Subcommittee on Regulation, Business Opportunities, and Technology-н дэлгэрэнгүй

Pricing of Drugs Codeveloped by Federal Laboratories and Private Companies: Hearing Before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, First Session, Washington, DC, January 25, 1993, Volume 4
United States. Congress. House. Committee on Small Business. Subcommittee on Regulation, Business Opportunities, and Technology
Үнэгүй
Pricing of Drugs Codeveloped by Federal Laboratories and Private Companies: Hearing Before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, First Session, Washington, DC, January 25, 1993, Volume 4
United States. Congress. House. Committee on Small Business. Subcommittee on Regulation, Business Opportunities, and Technology
Үнэгүй
Conflict of Interest, Protection of Public Ownership, in Drug Development Deals Between Tax-exempt, Federally Supported Labs and the Pharmaceutical Industry: Hearing Before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, First Session, Volume 103, Issue 25
United States. Congress. House. Committee on Small Business. Subcommittee on Regulation, Business Opportunities, and Technology
Үнэгүй
Questionable Sales Practices in the Drug Industry: Hearing Before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, Second Session, Washington, DC, October 12, 1994, Volume 4
United States. Congress. House. Committee on Small Business. Subcommittee on Regulation, Business Opportunities, and Technology
Үнэгүй

Төстэй электрон ном

Norplant and Contraceptive Pricing: Conflict of Interest, Protection of Public Ownership in Drug Development Deals Between Tax-exempt, Federally Supported Labs and the Pharmaceutical Industry : Hearing Before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, First Session, Part 3
United States. Congress. House. Committee on Small Business. Subcommittee on Regulation, Business Opportunities, and Technology
Үнэгүй
Empire of Pain: The Secret History of the Sackler Dynasty
Patrick Radden Keefe
Biographies & memoirs
4.6
$ 12.99
Underreporting Federal Involvement in New Technologies Developed at Scripps Research Institute: Hearing Before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, Second Session, Washington, DC, July 11, 1994, Volume 4
United States. Congress. House. Committee on Small Business. Subcommittee on Regulation, Business Opportunities, and Technology
Үнэгүй
No More Tears: The Dark Secrets of Johnson & Johnson
Gardiner Harris
Business & investing
3.7
$ 14.99$ 2.99